Tapestri Single-Cell MRD AML Multiomics Solution

The Tapestri Single-cell Measurable Residual Disease (scMRD) Multiomics Assay for Acute Myeloid Leukemia (AML) is the only solution that simultaneously conducts and integrates the genotypic and immunophenotypic assessment of AML MRD across thousands of individual cells, providing clonal insight in tandem with immunophenotype from rare residual disease cells. These high-resolution, integrated molecular profiles bring unprecedented clarity to the complex biology of AML MRD, powering actionable insights. Learn more about the workflow, bioinformatics report, and assay content.

VIEW

brochure

Tapestri Single-Cell Multiple Myeloma Multiomics Solution

FLYER

brochure

Multiplex Samples by Antibody Hashing

FLYER

brochure

Multiplex Samples by Genotyping

FLYER

brochure

Publication Highlight: Single-cell genotypic and phenotypic analysis of measurable residual disease in acute myeloid leukemia

FLYER

Tapestri Single-Cell MRD AML Multiomics Solution

SHARE THIS PAGE